Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7799900 Immunoglobulin variants and uses thereof

Patent 7799900 was granted and assigned to Genentech on September, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

77999000

Patent Inventor Names

Andrew C. Chan0

Camellia W. Adams0

Craig W. Crowley0

Gerald R. Nakamura0

Henry B. Lowman0

Leonard G. Presta0

Date of Patent

September 21, 2010

Patent Application Number

111477800

Date Filed

June 7, 2005

Patent Citations Received

‌

US Patent 12065469 De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals

‌

US Patent 11857628 Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation

‌

US Patent 11866498 Bispecific antigen-binding molecules and methods of use

Patent Primary Examiner

‌

Stephen L. Rawlings

Patent abstract

The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7799900 Immunoglobulin variants and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API